[ET Net News Agency, 4 November 2026] SBP GROUP (01177) rose 4.9% to HK$5.125.
It hits an intra-day high of HK$5.13, breaking above the 100-D SMA of HK$5.114, and an intra-day low of HK$4.815. The total shares traded was 56.98 million, with a value of HK$282.36m. The active buy/sell ratio is 68:32, with net buying turnover of HK$97.8m. CLSA LTD accounts for greatest net responsive buying turnover of HK$8.63m, with volume weighted average price of HK$4.921. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$19.77m, with volume weighted average price of HK$4.971. The stock has risen a combined 6.3% over the past 3 consecutive trading days.
The Hang Seng Index now rose 276 points, or 1.2% to 23,802.
Basic Information| Nominal | 5.125 | % Chg | +4.91% |
| High | 5.130 | Low | 4.815 |
| Shares Tr | 56.98m | Turnover | 282.36m |
| 10-D SMA | 4.906 | %H.V | 40.045 |
| 20-D SMA | 5.140 | VWAP | 4.955 |
| 50-D SMA | 5.388 | RSI14 | 48.688 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$97.8m, rising a combined 6.3% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SBP GROUP (01177) | 5.125 | +4.91 |
| SIHUAN PHARM (00460) | 0.730 | +1.39 |
| GRAND PHARMA (00512) | 4.255 | +0.24 |
| HENGRUI PHARMA (01276) | 51.250 | +0.69 |
| LIVZON PHARMA (01513) | 24.160 | +1.68 |
| LUYE PHARMA (02186) | 1.610 | +0.31 |
| FOSUN PHARMA (02196) | 16.950 | +0.47 |
| SH PHARMA (02607) | 11.190 | +1.08 |
| CHINARES PHARMA (03320) | 4.670 | -0.43 |
| HANSOH PHARMA (03692) | 33.700 | +5.51 |
(ed)
Nominal 
